JAX® Mice & Services

This webinar explores the Cre-lox recombinase system, with a focus on the appropriate selection of Cre drivers and loxP-flanked alleles, breeding strategies, and common pitfalls for achieving spatial and temporal control of genetic modifications in mice.

This event will focus on how Biotech companies and research institutes can accelerate therapeutic antibody discovery by improving the quality and diversity of its starting candidates. Attendees will learn how modern transgenic mouse platforms—specifically the Atlas™ Antibody Discovery platform—can reduce downstream engineering, expand human antibody diversity, and streamline early discovery workflows. Through performance data, practical guidance, and expert insights, the session will illustrate how better in vivo starting points can directly reduce program risk and failure rates.